Journal profile · Rheumatology
Aktuelle Rheumatologie
ISSN 0341-051X · eISSN 1438-9940 · Georg Thieme Verlag · GERMANY · Bimonthly · Founded 1976
Aktuelle Rheumatologie: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 0.14; subscription journal; review over 12 weeks (community reports); community-reported acceptance: easy; 120 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Aktuelle Rheumatologie is published by Georg Thieme Verlag and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Rheumatoid Arthritis Research and Therapies, Autoimmune and Inflammatory Disorders Research and Spondyloarthritis Studies and Treatments, together about 34.3% of its articles. Its main subfields are Rheumatology. (generated from OpenAlex topic counts and CAS ranking data)
Research area (LetPub): Rheumatology
Main research topics OpenAlex counts of recent articles; shares are approximate
- Rheumatoid Arthritis Research and TherapiesMedicine18.8%
- Autoimmune and Inflammatory Disorders ResearchMedicine7.8%
- Spondyloarthritis Studies and TreatmentsMedicine7.7%
- Systemic Lupus Erythematosus ResearchMedicine6.9%
- Musculoskeletal Disorders and RehabilitationMedicine5.3%
- Fibromyalgia and Chronic Fatigue Syndrome ResearchMedicine4.2%
- Medical Practices and RehabilitationHealth Professions4%
- Urticaria and Related ConditionsMedicine3.9%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Rheumatology | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Rheumatology | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Rheumatology | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 0.14LetPub ·
- CiteScore 2026-06
- 0.3LetPub ·
- SJR 2026-06
- 0.13LetPub ·
- SNIP 2026-06
- 0.1LetPub ·
- h-index
- 12LetPub ·
- h-index
- 15OpenAlex ·
- i10-index
- 59OpenAlex ·
- 2-year mean citedness
- 0.08OpenAlex ·
- Self-citation rate
- 0%LetPub ·
- Share of gold OA articles
- 4.76%LetPub ·
Volume
- Articles per year
- 21LetPub ·
Articles by year OpenAlex count · 4,142 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 92 | 0 | 14 |
| 2025 | 120 | 0 | 1 |
| 2024 | 133 | 2 | 13 |
| 2023 | 152 | 67 | 33 |
| 2022 | 154 | 139 | 56 |
| 2021 | 168 | 156 | 59 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
- Average review time (community reports)
- over 12 weeksLetPub ·
- Average acceptance (community reports)
- EasyLetPub ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Subscription journalLetPub
A subscription journal: articles are read by subscription or purchase, and authors usually pay no publication charge.
No source has fee information yet; check the journal's website.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- Georg Thieme Verlag
- Country or region
- GERMANY
- Language
- Multi-Language
- Frequency
- Bimonthly
- Founded
- 1976
- ISSN
- 0341-051X
- Electronic ISSN
- 1438-9940
- Official links
- Journal homepage ↗LetPub
- Submission system ↗LetPub
FAQ
Frequently asked questions about Aktuelle Rheumatologie
What CAS zone is Aktuelle Rheumatologie in?
In the 2025 upgraded edition of the CAS Journal Ranking, Aktuelle Rheumatologie is in Zone 4 of Medicine, and in Zone 4 of the minor category Rheumatology. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Aktuelle Rheumatologie?
The latest impact factor listed by LetPub is 0.14; CiteScore 0.3, h-index 15.
How long does peer review take at Aktuelle Rheumatologie?
Authors report an average review time of over 12 weeks; the community-reported acceptance is “Easy”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index Aktuelle Rheumatologie?
According to LetPub and DOAJ records, Aktuelle Rheumatologie is indexed in SCIE and Scopus.
Is Aktuelle Rheumatologie open access, and what is the APC?
Aktuelle Rheumatologie is a subscription journal. Fee information is not available yet; check the journal's website.
Sources and updates
The facts on this page come from LetPub, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .